Stock Fundamentals

LRMR.US Logo

LRMR.US - Current Price

$3.56

Company Information

▼
Company Name
Larimar Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US5171251003
CIK: 0001374690
CUSIP: 517125100
Currency: USD
Full Time Employees: 65
Phone: 844 511 9056
Website: https://larimartx.com
Fiscal Year End: December
IPO Date: Jun 19, 2014
Description:

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Address:

Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004

Directors & Officers

▼
Name Title Year Born
Dr. Carole S. Ben-Maimon M.D. CEO, President & Director 1959
Mr. Michael Celano CPA Secretary & CFO 1959
Dr. Gopi Shankar M.B.A., Ph.D. Chief Development Officer 1971
Mr. John Berman Vice President of Finance & Administration NA
Ms. Jennifer Spokes Johansson Vice President of Legal & Compliance NA
Dr. Russell G. Clayton Sr., D.O, D.O. Chief Medical Officer 1961
Mr. Francis Michael Conway CPA VP & Controller NA

Shares Statistics

▼
Shares Outstanding: 85.59M
Shares Float: 37.32M
% Insiders: 107.00%
% Institutions: 10,007.10%
Short % Float: 15.99%

Valuation Metrics

▼
Enterprise Value: $117.35M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $304.70M
EBITDA: $-139.43M
Book Value: $1.62
Earnings/Share: $-1.96
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -42.99%
ROE (TTM): -78.24%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.41 N/A 10,000.00%
Sep 30, 2025 -0.61 -0.41 N/A -4,777.13%
Jun 30, 2025 -0.41 -0.48 N/A 1,463.67%
Mar 31, 2025 -0.46 -0.41 N/A -1,244.19%
Dec 31, 2024 -0.45 -0.32 N/A -4,088.92%
Sep 30, 2024 -0.24 -0.37 N/A 3,513.51%
Jun 30, 2024 -0.34 -0.31 N/A -967.74%
Mar 31, 2024 -0.27 -0.23 N/A -1,739.13%
Dec 31, 2023 -0.30 -0.25 N/A -2,000.00%
Sep 30, 2023 -0.21 -0.22 N/A 454.55%
Jun 30, 2023 -0.19 -0.19 N/A 0.00%
Mar 31, 2023 -0.15 -0.25 N/A 4,000.00%
Dec 31, 2022 -0.21 -0.37 N/A 4,324.32%
Sep 30, 2022 -0.37 -0.42 N/A 1,190.48%
Jun 30, 2022 -0.47 -0.57 N/A 1,754.39%
Mar 31, 2022 -0.49 -0.51 N/A 392.16%
Dec 31, 2021 -0.50 -0.72 N/A 3,055.56%
Sep 30, 2021 -0.92 -0.64 N/A -4,375.00%
Jun 30, 2021 -0.79 -0.75 N/A -533.33%
Mar 31, 2021 -0.76 -0.86 N/A 1,162.79%
Dec 31, 2020 -0.89 -0.70 N/A -2,714.29%
Sep 30, 2020 -0.64 -2.28 N/A 7,192.98%
Jun 30, 2020 -1.21 -2.16 N/A 4,398.15%
Mar 31, 2020 -1.20 -2.28 N/A 4,736.84%
Dec 31, 2019 -2.28 -2.28 N/A 0.00%
Sep 30, 2019 -2.88 -3.20 N/A 1,000.00%
Jun 30, 2019 -3.84 -4.38 N/A 1,232.88%
Mar 31, 2019 -4.20 -5.09 N/A 1,748.53%
Dec 31, 2018 -4.68 -5.26 N/A 1,102.66%
Sep 30, 2018 -4.92 -5.64 N/A 1,276.60%
Jun 30, 2018 -6.84 -7.08 N/A 338.98%
Mar 31, 2018 -6.96 -6.18 N/A -1,262.14%
Dec 31, 2017 -5.76 -6.84 N/A 1,578.95%
Sep 30, 2017 -5.52 -6.92 N/A 2,023.12%
Jun 30, 2017 -5.88 -6.24 N/A 576.92%
Mar 31, 2017 -5.76 -5.21 N/A -1,055.66%
Dec 31, 2016 -4.56 -6.03 N/A 2,437.81%
Sep 30, 2016 -6.48 -7.28 N/A 1,098.90%
Jun 30, 2016 -6.60 -7.94 N/A 1,687.66%
Mar 31, 2016 -7.80 -8.85 N/A 1,186.44%
Dec 31, 2015 -10.20 -9.58 N/A -647.18%
Sep 30, 2015 -8.76 -9.50 N/A 778.95%
Jun 30, 2015 -7.92 -8.49 N/A 671.38%
Mar 31, 2015 -6.36 -7.74 N/A 1,782.95%
Dec 31, 2014 -5.76 -7.85 N/A 2,662.42%
Sep 30, 2014 -7.20 -11.07 N/A 3,495.93%
Jun 30, 2014 -33.12 -30.93 N/A -708.05%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $33.22M $N/A $200.23M $28.41M $171.81M
2023-12-31 $26.75M $N/A $95.94M $14.22M $81.72M
2022-12-31 $26.83M $N/A $126.41M $15.50M $110.90M
2021-12-31 $70.10M $N/A $78.67M $14.25M $64.41M
2020-12-31 $68.15M $N/A $104.69M $14.99M $89.69M
2019-12-31 $1.01M $N/A $5.20M $5.90M $-694.00K
2018-12-31 $49.33M $N/A $121.76M $28.49M $93.27M
2017-12-31 $40.78M $N/A $105.51M $27.29M $78.22M
2016-12-31 $32.35M $N/A $131.62M $9.89M $121.73M
2015-12-31 $35.60M $N/A $189.11M $20.00M $169.11M
2014-12-31 $58.10M $N/A $117.52M $13.08M $104.44M
2013-12-31 $35.52M $N/A $38.14M $2.92M $35.22M
2012-12-31 $9.94M $N/A $10.99M $2.93M $8.06M
2011-12-31 $N/A $N/A $N/A $N/A $N/A

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jul 31, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist